Health Sciences In The Media

Lily Nguyen, a student in the College of Medicine – Tucson, is the recipient of a White Coat Investor Scholarship in the "inspirational" category.

When it comes to your health, what you put into your body goes a long way. That's no different for your lungs.

Andrew Weil, MD, founder and director of the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson, warns that parsley, which helps improve halitosis and is also rich in vitamin K, can interfere with blood thinners.

Phillip Kuo, MD, PhD, professor of medical imaging in the College of Medicine – Tucson, explained how a post-hoc exploratory analysis of PSMA PET scans resulted in a better understanding of which patients are likely to respond better to treatment with lutetium-PSMA-617.

The Mel and Enid Zuckerman College of Public Health and the University of Limerick School of Medicine’s Master of Science Public Health program in Ireland have entered into an International Memorandum of Agreement to enhance cooperation in research and academics.

Gabriela Valdez, PhD, assistant professor and director of Global Health Programs and Global Education in the Mel and Enid Zuckerman College of Public Health, is piloting a class for the National Center for Interpretation's new Multilingual Curriculum Project.

The Arizona Center for Rural Health's recently released Physician Specialty Workforce Profile reveals the significant physician shortages in rural areas of the state.

Ricardo Correa, MD, director of the Endocrinology, Diabetes and Metabolism Fellowship Program in the College of Medicine – Phoenix, offered insight on the residency interview process.

Jeff Burgess, MD, PhD, professor in the Mel and Enid Zuckerman College of Public Health, spoke about recent strides in firefighter cancer research at the National Emergency Training Center U.S. Fire Administrator’s Summit on Fire Prevention and Control.

In patients with Type 2 diabetes, thiazolidinedione monotherapy is associated with reduced dementia risk and sulfonylurea monotherapy is associated with an increased risk compared with metformin monotherapy.